
The innovations transforming reproductive medicine and giving hope to millions of prospective parents across the globe are being recognised at the Femtech World Awards.
Infertility is a global health issue affecting millions of people of reproductive age worldwide.
About 17.5 per cent of the global adult population – roughly one in six – will experience infertility at some point in their lifetime, according to the World Health Organization, showing the urgent need to increase access to affordable, high-quality fertility care.
Femtech World is looking for innovators who are developing novel solutions to reshape fertility care and improve access to treatment.
Through the Fertility Innovation Award, sponsored by FinDBest IVF, Femtech World aims to shine a light on the life-changing work of those developing next-generation innovations that could not only increase success rates but revolutionise the world of reproductive health as we know it.
FinDBest IVF connects IVF medical device manufacturers with an expansive network of over 750 pre-vetted distributors in more than 150 countries.
Supported by seasoned medtech experts, the cutting-edge platform ensures quality partnerships, global reach, and a user-friendly interface.

Juan Jiménez, founder and CEO of FinDBest IVF, said: “At FinDBest IVF, we are dedicated to driving innovation and ensuring accessibility of cutting-edge IVF technologies.
“Our mission is to connect manufacturers with trusted global distributors, making advanced solutions available to families worldwide. Proudly sponsoring the Femtech 2025 Fertility Innovation Award, we help turn the dream of parenthood into a reality.”
Femtech World editor, Sorina Mihaila, said: “The science surrounding research on embryos means that new, innovative technologies appear on our radar every day.
“We are looking forward to showcasing the emerging stars in the fertility space at the 2025 Femtech World Awards.”
Find out more about the awards and enter for free here.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









